Tag: Diabetes: Type II
Eucaloric Carbohydrate-Restricted Diet Improves β-Cell Function in T2DM
Significant effect on acute and maximal C-peptide response at 12 weeks seen with carbohydrate-restricted diet
Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
Recellularization via electroporation therapy found to be feasible and safe
Risk for Type 2 Diabetes Increased for Children After SARS-CoV-2 Infection
Risk increased in the six months after infection; elevated risk also seen in subpopulation with overweight, obesity and hospitalized patients
Metabolic-Bariatric Surgery Tied to Reduced Risk for Pancreatic Cancer in Those With Obesity
Reduced risk was more pronounced in those with type 2 diabetes, but was also seen in those without T2D
Type 2 Diabetes Incidence Up With Higher Intake of Ultraprocessed Food
Heterogeneity was seen across UPF subtypes, with lower incident type 2 diabetes for breads, cereals, plant-based alternatives
Metabolic Surgery Is Renoprotective in Patients With Obesity, CKD
Metabolic surgery linked to lower risk for progression of kidney impairment compared with GLP-1RA
Semaglutide May Lower Risk for Opioid Overdose in T2DM, Opioid Use Disorder
Compared with other antidiabetes medications, semaglutide linked to lower risk for patients with comorbid opioid use disorder
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
Reduced risk for Alzheimer disease, vascular dementia, and Parkinson disease seen with SGLT2i use in type 2 diabetes
Personality Tied to Cardiovascular Disease Risk With Type 2 Diabetes
Lower diligence level linked to risk for new cardiovascular disease, but healthy lifestyle still beneficial
Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide
Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage